Clinical Trial Update: Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide with or without rituximab after standard chemotherapy in patients with diffuse large B-cell lymphoma; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-04-11